CD20-specific antibodies and methods of employing same

Details for Australian Patent Application No. 2004252067 (hide)

International Classifications

Event Publications

22 December 2005 PCT application entered the National Phase

PCT publication WO2005/000901 Priority application(s): WO2005/000901

19 April 2007 Amendment Made

The nature of the amendment is as shown in the statement(s) filed 13 Mar 2007

26 April 2007 Section 223 Application Received

Duke University An application to extend the time from 06 Jan 2006 to 06 Jan 2007 in which to comply with Section 6(c) has been filed . Address for service in Australia - Shelston IP Level 21 60 Margaret Street Sydney NSW 2000

5 July 2007 Section 223 Application Allowed

Duke University The time in which to comply with Section 6(c) has been extended to 06 Jan 2007. Address for service in Australia - Shelston IP Level 21 60 Margaret Street Sydney NSW 2000 2005

12 April 2012 Application Accepted

Published as AU-B-2004252067

9 August 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.